BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7598744)

  • 1. Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism.
    Ward RJ; Dexter D; Florence A; Aouad F; Hider R; Jenner P; Crichton RR
    Biochem Pharmacol; 1995 Jun; 49(12):1821-6. PubMed ID: 7598744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
    Florence A; Ward RJ; Peters TJ; Crichton RR
    Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
    Dexter DT; Ward RJ; Florence A; Jenner P; Crichton RR
    Biochem Pharmacol; 1999 Jul; 58(1):151-5. PubMed ID: 10403528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of iron from (3,5,5-trimethylhexanoyl)ferrocene in rats. A dietary model for severe iron overload.
    Nielsen P; Heinrich HC
    Biochem Pharmacol; 1993 Jan; 45(2):385-91. PubMed ID: 8435091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic feeding of carbonyl-iron and TMH-ferrocene in rats. Comparison of two iron-overload models with different iron absorption.
    Nielsen P; Heinelt S; Düllmann J
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Oct; 106(2):429-36. PubMed ID: 7904915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of iron storage in the rat heart following iron overloading with trimethylhexanoyl-ferrocene.
    Braumann A; Wulfhekel U; Nielsen P; Balkenhol B; Düllmann J
    Acta Anat (Basel); 1994; 150(1):45-54. PubMed ID: 7976187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,5,5-Trimethylhexanoylferrocene induction of heme oxygenase activity in normal hepatocytes.
    Lambrecht RW; Cable JW; Pepe JA; Bonkovsky HL
    Biochem Pharmacol; 1994 Apr; 47(9):1669-76. PubMed ID: 8185682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat.
    Choudhury R; Singh S
    Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron.
    Cable EE; Connor JR; Isom HC
    Am J Pathol; 1998 Mar; 152(3):781-92. PubMed ID: 9502420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis.
    Ward RJ; Florence AL; Baldwin D; Abiaka C; Roland F; Ramsey MH; Dickson DP; Peters TJ; Crichton RR
    Eur J Biochem; 1991 Dec; 202(2):405-10. PubMed ID: 1761043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydroxypyridones and desferrioxamine on the mobilization of aluminium from tissues of aluminium-loaded rats.
    Florence AL; Gauthier A; Ward RJ; Crichton RR
    Neurodegeneration; 1995 Dec; 4(4):449-55. PubMed ID: 8846239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat liver regeneration in the presence of nonbenzenoid aromatic agents: ferrocenes and cycloheptatrienes.
    Gershbein LL
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):139-45. PubMed ID: 7360994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between dopamine and iron contents in the brain of parkinsonian rats].
    Jiang H; Chen WF; Xie JX
    Sheng Li Xue Bao; 2001 Oct; 53(5):334-8. PubMed ID: 11833414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethane exhalation and vitamin E/ubiquinol status as markers of lipid peroxidation in ferrocene iron-loaded rats.
    Dresow B; Albert C; Zimmermann I; Nielsen P
    Hepatology; 1995 Apr; 21(4):1099-105. PubMed ID: 7705785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of aromatic or heteroaromatic groups in nonsteroidal antiinflammatory agents with the ferrocene group.
    Maryanoff BE; Keeley SL; Persico FJ
    J Med Chem; 1983 Feb; 26(2):226-9. PubMed ID: 6827541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary lipophilic iron accelerates regional brain iron-load in C57BL6 mice.
    Peters DG; Purnell CJ; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
    Brain Struct Funct; 2018 Apr; 223(3):1519-1536. PubMed ID: 29168009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directed hydroxyl radical probing using iron(II) tethered to RNA.
    Joseph S; Noller HF
    Methods Enzymol; 2000; 318():175-90. PubMed ID: 10889988
    [No Abstract]   [Full Text] [Related]  

  • 19. Ferrous and ferric iron accumulates in the brain of aged Long-Evans Cinnamon rats, an animal model of Wilson's disease.
    Kim JM; Ko SB; Kwon SJ; Kim HJ; Han MK; Kim DW; Cho SS; Jeon BS
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):143-7. PubMed ID: 15911138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system.
    Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G
    Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.